ClinicalTrials.Veeva

Menu

Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial

U

University of Roma La Sapienza

Status

Enrolling

Conditions

Lumbar Spine Degeneration
Lumbar Spinal Stenosis
Lumbar Spondylolisthesis
Lumbar Spine Instability

Treatments

Procedure: Percutaneous Spacer
Procedure: Minimally invasive surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT05527145
URomLS-0137/22

Details and patient eligibility

About

Symptomatic lumbar spinal stenosis is the most common indication for spinal surgery. However, more than one-third of the patients undergoing surgery for lumbar stenosis report dissatisfaction with the results. On the other hand, conservative treatment has shown positive results in some cases. This trial will compare the outcomes of surgical versus non-surgical treatment for lumbar stenosis.

Full description

This is a three-centre randomised controlled trial in which 200 patients with symptomatic lumbar spinal stenosis will be randomised into one of two treatment arms. The patients in the surgical arm will undergo decompression of the neural structures by use of any open or minimally invasive (MIS) technique with or without fusion; the patients in the non-surgical arm will undergo imaging assisted percutaneous interspinous spacer insertion with fusion.

The primary outcome of the study will be the Oswestry Disability Index. Secondary outcomes will include motor amplitude and degree of denervation activity obtained by means of nerve conduction studies and electromyography.

Patient-reported outcome measures will be also used as secondary outcomes.

Enrollment

200 estimated patients

Sex

All

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 50-85 years.
  2. Clinical symptoms of lumbar spinal stenosis (pseudoclaudication) indicating and motivating surgery. Numeric Rating Scale in lower limbs ≥3.
  3. MRI with finding of lumbar spinal stenosis at 1-3 lumbar levels. Dural sac area ≤75 mm2 or degree of stenosis C or D according to Schizas's classification.34
  4. The patient has given oral and written informed consent to participate.

Exclusion criteria

  1. Degenerative deformity with Cobb angle >20°.
  2. Symptomatic osteoarthritis in the lower limbs that affects and limits the patient's function.
  3. Arterial insufficiency (claudication intermittent).
  4. Former lumbar surgery other than disc hernia.
  5. Conditions that affect the spine, such as ankylosing spondylitis, diffuse idiopathic skeletal hyperostosis, spondylodiscitis/infections, malignancy and neurological diseases.
  6. Heart and lung diseases presenting a significant risk for surgery or making it impossible for the patient to take part in a percutaneous arm of treatment (American Society of Anesthesiologists (ASA) score >3).
  7. Polyneuropathies.
  8. Psychological factors rendering the patient incapable of inclusion in the trial (eg, drug addiction, dementia).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

200 participants in 2 patient groups

surgery
Active Comparator group
Description:
Oper or minimally invasive surgery
Treatment:
Procedure: Minimally invasive surgery
percutaneous
Active Comparator group
Description:
percutaneous non-surgical insertion of interspinous device
Treatment:
Procedure: Percutaneous Spacer

Trial contacts and locations

1

Loading...

Central trial contact

silvia ciotti; Alessandro napoli, md, phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems